Inhibition of cardiac fibroblast proliferation and myofibroblast differentiation by resveratrol

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 3 57-3, 2005, Pages

  Olson, Erik R ^a   Naugle, Jennifer E ^a   Zhang, Xiaojin ^a   Bomser, Joshua A ^b   Meszaros, J Gary ^a  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Angiotensin II; Fibrosis; Mitogen activated protein kinase; Remodeling

Indexed keywords

ALPHA ACTIN; ANGIOTENSIN; ANTIFIBROTIC AGENT; EPIDERMAL GROWTH FACTOR; LEUCINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; RESVERATROL; SCLEROPROTEIN; THYMIDINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL SECRETION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EXTRACELLULAR MATRIX; FIBROBLAST; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART VENTRICLE REMODELING; INHIBITION KINETICS; MALE; MYOFIBROBLAST; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT;

ANGIOTENSIN II; ANIMALS; ANTIOXIDANTS; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; DRUG INTERACTIONS; EPIDERMAL GROWTH FACTOR; FIBROBLASTS; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOCARDIUM; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION; STILBENES; VASOCONSTRICTOR AGENTS;

EID: 13944256603     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00763.2004     Document Type: Article

References (31)

1. 2+ in angiotensin II-induced mitogenesis of cardiac fibroblasts. Am J Physiol Cell Physiol 267: C1308-C1318, 1994.
2. Brilla CG, Scheer C, and Rupp H. Renin-angiotensin system and myocardial collagen matrix: modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism. J Hypertens Suppl 15: S13-S19, 1997.
3. Burlew BS and Weber KT. Cardiac fibrosis as a cause of diastolic dysfunction. Herz 27: 92-98, 2002.
4. Campbell SE and Katwa LC. Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts. J Mol Cell Cardiol 29: 1947-1958, 1997.
5. Desmouliere A, Redard M, Darby I, and Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 146: 56-66, 1995.
6. Dostal DE, Booz GW, and Baker KM. Angiotensin II signalling pathways in cardiac, fibroblasts: conventional versus novel mechanisms in mediating cardiac growth and function. Mol Cell Biochem 157: 15-21, 1996.
7. Dugourd C, Gervais M, Corvol P, and Monnot C. Akt is a major downstream target of PI3-kinase involved in angiotensin II-induced proliferation. Hypertension 41: 882-890, 2003.
8. Eguchi S, Dempsey PJ, Frank GD, Motley ED, and Inagami T. Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease- dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK. J Biol Chem 276: 7957-7962, 2001.
9. El-Mowafy AM. Resveratrol activates membrane-bound guanylyl cyclase in coronary arterial smooth muscle: a novel signaling mechanism in support of coronary protection. Biochem Biophys Res Commun 291: 1218-1224, 2002.
10. El-Mowafy AM and White RE. Resveratrol inhibits MAPK activity and nuclear translocation in coronary artery smooth muscle: reversal of endothelin-1 stimulatory effects. FEBS Lett 451: 63-67, 1999.
11. Ford CM, Li S, and Pickering JG. Angiotensin II stimulates collagen synthesis in human vascular smooth muscle cells. Involvement of the AT(1) receptor, transforming growth factor-beta, and tyrosine phosphorylation. Arterioscler Thromb Vasc Biol 19: 1843-1851, 1999.
12. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 200: 500-503, 2003.
13. Haider UG, Sorescu D, Griendling KK, Vollmar AM, and Dirsch VM. Resveratrol suppresses angiotensin II-induced Akt/protein kinase B and p70 S6 kinase phosphorylation and subsequent hypertrophy in rat aortic smooth muscle cells. Mol Pharmacol 62: 772-777, 2002.
14. Kim J, Eckhart AD, Eguchi S, and Koch WJ. Beta-adrenergic receptor-mediated DNA synthesis in cardiac fibroblasts is dependent on transactivation of the epidermal growth factor receptor and subsequent activation of extracellular signal-regulated kinases. J Biol Chem 277: 32116-32123, 2002.
15. Kuwahara F, Kai H, Tokuda K, Kai M, Takeshita A, Egashira K, and Imaizumi T. Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 106: 130-135, 2002.
16. Lee AA, Dillmann WH, McCulloch AD, and Villarreal FJ. Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts. J Mol Cell Cardiol 27: 2347-2357, 1995.
17. Lijnen P, Petrov V, Rumilla K, and Fagard R. Transforming growth factor-beta 1 promotes contraction of collagen gel by cardiac fibroblasts through their differentiation into myofibroblasts. Methods Find Exp Clin Pharmacol 25: 79-86, 2003.
18. Lijnen PJ, Petrov VV, and Fagard RH. Induction of cardiac fibrosis by transforming growth factor-beta(1). Mol Genet Metab 71: 418-435, 2000.
19. s. Am J Physiol Cell Physiol 278: C154-C162, 2000.
20. Meszaros JG, Raphael R, Lio FM, and Brunton LL. Protein kinase C contributes to desensitization of ANG II signaling in adult rat cardiac fibroblasts. Am J Physiol Cell Physiol 279: C1978-C1985, 2000.
21. Orallo F, Alvarez E, Camina M, Leiro JM, Gomez E, and Fernandez P. The possible implication of trans-Resveratrol in the cardioprotective effects of long-term moderate wine consumption. Mol Pharmacol 61: 294-302, 2002.
22. Petrov VV, Fagard RH, and Lijnen PJ. Stimulation of collagen production by transforming growth factor-beta1 during differentiation of cardiac fibroblasts to myofibroblasts. Hypertension 39: 258-263, 2002.
23. Schorb W, Booz GW, Dostal DE, Conrad KM, Chang KC, and Baker KM. Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ Res 72: 1245-1254, 1993.
24. Schorb W, Conrad KM, Singer HA, Dostal DE, and Baker KM. Angiotensin II is a potent stimulator of MAP-kinase activity in neonatal rat cardiac fibroblasts. J Mol Cell Cardiol 27: 1151-1160, 1995.
25. Stockand JD and Meszaros JG. Aldosterone stimulates proliferation of cardiac fibroblasts by activating Ki-RasA and MAPK1/2 signaling. Am J Physiol Heart Circ Physiol 284: H176-H184, 2003.
26. Tharaux PL, Chatziantoniou C, Fakhouri F, and Dussaule JC. Angiotensin II activates collagen I gene through a mechanism involving the MAP/ER kinase pathway. Hypertension 36: 330-336, 2000.
27. Tian B, Liu J, Bitterman P, and Bache RJ. Angiotensin II modulates nitric oxide-induced cardiac fibroblast apoptosis by activation of AKT/ PKB. Am J Physiol Heart Circ Physiol 285: H1105-H1112, 2003.
28. Villarreal FJ, Kim NN, Ungab GD, Printz MP, and Dillmann WH. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation 88: 2849-2861, 1993.
29. Voisin L, Foisy S, Giasson E, Lambert C, Moreau P, and Meloche S. EGF receptor transactivation is obligatory for protein synthesis stimulation by G protein-coupled receptors. Am J Physiol Cell Physiol 283: C446-C455, 2002.
30. Weber KT, Sun Y, and Katwa LC. Myofibroblasts and local angiotensin II in rat cardiac tissue repair. Int J Biochem Cell Biol 29: 31-42, 1997.
31. Yu R, Hebbar V, Kim DW, Mandlekar S, Pezzuto JM, and Kong AN. Resveratrol inhibits phorbol ester and UV-induced activator protein 1 activation by interfering with mitogen-activated protein kinase pathways. Mol Pharmacol 60: 217-224, 2001.